News

Read Young Innovator profile on Dr. Diana Ranoa, describing her pivotal role in developing the UIUC saliva test for COVID-19.

Young Innovator Program Inventor Spotlight: Diana Ranoa, describing her pivotal role in developing the UIUC saliva test for COVID-19. Diana ...
Read More

Congratulations to graduate student Matthew Boudreau for being awarded a prestigious fellowship from NCI!

Matthew Boudreau, a chemistry PhD candidate in the CCIL Deputy Director Paul Hergenrother’s lab, has been awarded the prestigious F99/K00 grant ...
Read More
Head shot of Prof. Paul Hergenrother

A compound for breast cancer discovered and developed in the Hergenrother and Shapiro labs has been licensed to Bayer

Paul Hergenrother helps discover cancer compound now in licensing deal. Researchers affiliated with the Cancer Center at Illinois discovered a ...
Read More

Congratulations to Riley Svec

Riley Svec was awarded a position on the NIH Chemistry-Biology Interface Training Grant. He was an Advanced Graduate Student speaker ...
Read More

Congratulations to Kristen Muñoz for being awarded a position on the NIH Chemistry-Biology Interface Training Grant!

Gram-negative bacteria have emerged that are resistant to most antibiotics, a troubling trend since a new class of antibiotics for ...
Read More

Congratulations to two students for receiving NSF Research Fellowships

We congratulate graduate student Martin Garcia Chavez and undergraduate Amanda Cowfer for being awarded NSF Research Fellowships! ...
Read More

See story on Pretzel, a pet dog with glioma successfully treated with PAC-1.

Clinical trials on companion animals diagnosed with cancer have brought new hope to their owners—and new data for a cutting-edge ...
Read More
PAC-1

A Phase 1b clinical trial of PAC-1 for glioblastoma patients has begun

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with ...
Read More

eNTRyway is LIVE!

eNTRyway is our web app for predicting compound accumulation in Gram-negative bacteria. It predicts the likelihood of a small-molecule to ...
Read More

Congratulations to Dr. Sarah Tasker for being awarded a postdoctoral fellowship

We congratulate Dr. Sarah Tasker on being awarded a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation ...
Read More

The FDA grants Orphan Drug Designation to PAC-1!

Human trials of cancer drug PAC-1 continue with new investment. University of Illinois chemistry professor Paul Hergenrother, right, and veterinary ...
Read More
PAC-1

PAC-1 shows efficacy in dog trial

Chasing cancer with dogs — Treating canine cancers is helping researchers learn more about human forms of the disease. Thunder is ...
Read More

The Phase 1 clinical trial of PAC-1 in human cancer patients has begun!

See listing on clinicaltrials.gov, listen to the interview, watch a PBS documentary about comparative oncology including PAC-1, and watch the ...
Read More

Congratulations to Evi Llabani

Evi Llabani receives the inaugural C*Star Fellowship from the Cancer Center at Illinois ...
Read More

Vanquish Oncology, Inc. announces multimillion dollar investment to move PAC-1 to human clinical trials for cancer patients.

Cancer drug tested in pet dogs is now bound for human trials. University of Illinois chemistry professor Paul Hergenrother, left, ...
Read More